Abiomed gets FDA nod for Impella ECP pivotal heart pump in clinical trial
The US Food and Drug Administration (FDA) has cleared Abiomed to use the company’s version of Impella ECP pivotal heart pump in pivotal clinical trial. The Impella ECP pivotal clinical trial is a single-arm, prospective, and multi-center trial and has enrolled the first two patients. The clinical trial will assess the rate of major adverse […]